Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "Korea"

111 News Found

European Commission approves Celltrion’s Covid-19 medicine
Drug Approval | November 15, 2021

European Commission approves Celltrion’s Covid-19 medicine

The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week


Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays
Digitisation | November 01, 2021

Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays

It provides an option to automatically perform nodule detection immediately after chest X-ray imaging


Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
Healthcare | October 08, 2021

Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion

The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio


NF Healthcare launch latest version of its oxygen generators
Healthcare | September 06, 2021

NF Healthcare launch latest version of its oxygen generators

The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour


DCGI approves Enzene biosimilar Denosumab for Osteoporosis
Drug Approval | August 28, 2021

DCGI approves Enzene biosimilar Denosumab for Osteoporosis

This is Enzene Biosciences third biosimilar to be approved


Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026
Supply Chain | August 11, 2021

Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026

A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report


ALS drug RADICAVA holds promise as it completes four years in US
News | August 10, 2021

ALS drug RADICAVA holds promise as it completes four years in US

Nearly 6,000 patients have been treated with the drug since 2017


S-Alpha Therapeutics raises US $ 8.7 million in Series A Funding
Digitisation | August 10, 2021

S-Alpha Therapeutics raises US $ 8.7 million in Series A Funding

Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology


Glenmark Life Sciences IPO to open on July 27, 2021
News | July 26, 2021

Glenmark Life Sciences IPO to open on July 27, 2021

The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration


Lasa Supergenerics FY21 profit up 521%
News | June 02, 2021

Lasa Supergenerics FY21 profit up 521%

Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%